🇺🇸 FDA
Pipeline program

IONIS-PKKRx (ISIS 546254)

15-001IS

Phase 2 small_molecule completed

Quick answer

IONIS-PKKRx (ISIS 546254) for Chronic Migraine is a Phase 2 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
IONIS PHARMACEUTICALS INC
Indication
Chronic Migraine
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials